DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Up 5.2% Today

What is DENTSPLY SIRONA Inc.?

XRAY is the ticker symbol for Dentsply Sirona Inc., a company specializing in dental equipment and technology. The overall market for dental products has been facing challenges due to macroeconomic factors and company-specific issues.

Why is DENTSPLY SIRONA Inc. going up?

XRAY stock is up 5.2% on Dec 11, 2024 14:41

• The bullish movement in XRAY stock could be attributed to investors finding reasons to retain Dentsply Sirona stock in their portfolios despite the ongoing challenges.
• The pending securities fraud class action lawsuit may have initially caused some uncertainty and volatility in the stock price, but investors seem to have gained confidence in the company's product portfolio.
• Despite the deadline alerts reminding investors of potential losses, the stock managed to have a strong bullish movement, indicating that some positive news or developments might have overshadowed these concerns.
• Overall, the market movement suggests that investors are focusing more on the company's product traction and potential growth rather than the pending legal issues and macroeconomic challenges.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

Dentsply Sirona Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 27, 2025 to Discuss Your Rights - XRAY - Dentsply Sirona ( NASDAQ:XRAY )

NEW YORK, Dec. 10, 2024 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. XRAY. Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

https://www.benzinga.com/pressreleases/24/12/g42420175/dentsply-sirona-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-befor

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

XRAY continues to gain traction from a robust product portfolio. However, the suspension of Byte's business and macroeconomic factors, such as weakened global demand, persist.

https://www.zacks.com/stock/news/2381132/reasons-to-retain-dentsply-sirona-stock-in-your-portfolio-now

DENTSPLY SIRONA INC. ( NASDAQ: XRAY ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DENTSPLY SIRONA Inc. Investors of Upcoming Deadline - Dentsply Sirona ( NASDAQ:XRAY )

NEW YORK, Dec. 09, 2024 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of DENTSPLY SIRONA Inc. XRAY? Did you purchase your shares between December 1, 2022 and November 6, 2024, inclusive? Did you lose money in your investment in DENTSPLY SIRONA Inc.?

https://www.benzinga.com/pressreleases/24/12/g42394975/dentsply-sirona-inc-nasdaq-xray-deadline-alert-bernstein-liebhard-llp-reminds-dentsply-sirona-inc-

Trending Today

XRP ($XRP) Crypto Forecast: Up 5.3% Today

Bonk ($BONK) Crypto Forecast: Up 5.1% Today

Optimism ($OP) Crypto Forecast: Up 5.0% Today

Stellar ($XLM) Crypto Forecast: Up 5.1% Today

Pepe ($PEPE) Crypto Forecast: Up 5.0% Today

Chainlink ($LINK) Crypto Forecast: Up 5.0% Today

Ethereum Name Service ($ENS) Crypto Forecast: Up 5.2% Today

Aave ($AAVE) Crypto Forecast: Up 5.1% Today

Aptos ($APT) Crypto Forecast: Up 5.3% Today

Sui ($SUI) Crypto Forecast: Up 5.0% Today

DENTSPLY SIRONA Inc. Price History

20.07.2024 - XRAY Stock was down 5.1%

• The bearish movement in XRAY stock today could be attributed to the unexpected departure of CFO Glenn Coleman, leading to uncertainty among investors.
• Investors may be concerned about the implications of a key executive leaving the company, potentially signaling internal issues or strategic changes.
• The departure of a CFO can sometimes indicate financial challenges or mismanagement, causing investors to react negatively and sell off shares of the company.

14.10.2023 - XRAY Stock was up 5.0%

• XRAY had a strong bullish movement today, possibly driven by the announcement of their participation in upcoming investor conferences. This indicates potential positive developments or opportunities for the company.
• Additionally, the news about Dentsply Sirona's new $1B share buyback program could have boosted investor confidence and contributed to the bullish market movement.
• The company's plans for above-consensus earnings by 2026 might have also attracted investors, further driving the bullish sentiment.
• Overall, the combination of positive conference participation, share buyback program, and earnings outlook likely influenced the bullish market movement for XRAY.

29.01.2024 - XRAY Stock was down 5.4%

• Despite higher sales reported for Q4 2023, the market may have reacted bearishly due to a net loss for FY23.
• The departure of a board member might have added to the negative sentiment surrounding the stock, signaling potential internal challenges.
• The mixed FY24 guidance offered by Dentsply Sirona could have contributed to investor uncertainty, leading to the bearish market movement.
• Overall, the combination of a net loss, board member departure, and uncertain future guidance likely influenced the bearish trend in XRAY stock today.

01.02.2024 - XRAY Stock was down 5.4%

• Despite higher sales for Q4 2023, Dentsply Sirona Inc. (XRAY) witnessed a strong bearish movement in the stock market today.
• The market reaction to the company's net loss for FY23, despite modest revenue growth, was negative.
• The upcoming departure of a board member might have also contributed to the bearish sentiment surrounding XRAY.
• Mention of challenging macro headwinds in the earnings report could have further reduced investor confidence, influencing the bearish market movement.

29.01.2024 - XRAY Stock was down 1.5%

• The bearish movement in XRAY stock could be attributed to the mixed FY24 guidance provided by Dentsply Sirona, despite posting a Q4 earnings beat.
• The net loss reported for FY23 amidst modest revenue growth might have also contributed to the negative sentiment surrounding the stock.
• The upcoming departure of a board member, Eric K. Brandt, could have added uncertainty and potential instability to the company's leadership, impacting investor confidence.
• Despite reporting higher sales for Q4 2023, the overall market reaction to the earnings summary may have been overshadowed by concerns over the company's financial performance and future outlook.

02.09.2024 - XRAY Stock was down 5.5%

• The decline in XRAY's stock price could be linked to various macroeconomic challenges, including weakened global demand, increased costs, and currency fluctuations.
• Despite its diverse product portfolio, these external factors appear to have impacted investor sentiment, leading to the stock's downturn.
• Investors may remain wary about the company's future performance until there is more clarity on DENTSPLY SIRONA's strategy to address the current economic challenges.

25.09.2024 - XRAY Stock was down 5.3%

• Dentsply Sirona's decision to voluntarily suspend sales and marketing of Byte Aligners and Impression Kits could have raised concerns among investors about the company's revenue stream and future growth prospects.
• The upcoming conference call to discuss updates on Byte Aligner products might have failed to reassure investors, leading to a lack of confidence in the company's ability to address the issues effectively.
• The select preliminary third-quarter results provided by Dentsply Sirona could have indicated weaker performance than expected, contributing to the negative sentiment surrounding the stock.

13.08.2024 - XRAY Stock was up 5.2%

• The launch of Primescan 2, the new-generation intraoral scanner, is anticipated to fuel growth and market sentiment for XRAY.
• The innovative technology is expected to draw in more customers and bolster the company's competitiveness in the dental equipment sector.
• Investors are positive about the potential rise in revenue and enhanced customer satisfaction resulting from Primescan 2, contributing to today's bullish market movement.

11.11.2024 - XRAY Stock was up 5.2%

• The bullish movement in XRAY stock could be attributed to investors finding reasons to retain Dentsply Sirona stock in their portfolios despite the ongoing challenges.
• The pending securities fraud class action lawsuit may have initially caused some uncertainty and volatility in the stock price, but investors seem to have gained confidence in the company's product portfolio.
• Despite the deadline alerts reminding investors of potential losses, the stock managed to have a strong bullish movement, indicating that some positive news or developments might have overshadowed these concerns.
• Overall, the market movement suggests that investors are focusing more on the company's product traction and potential growth rather than the pending legal issues and macroeconomic challenges.

07.10.2024 - XRAY Stock was down 25.2%

• Despite exceeding earnings and revenue expectations in the third quarter, Dentsply Sirona's stock faced downward pressure following a revised guidance for fiscal 2024.
• The revised forecast for 2024, attributed to macroeconomic factors, competition, and lower demand, elicited concerns among investors and led to a decline in the stock price.
• The market response may reflect apprehension surrounding future growth despite positive performance in specific segments during the quarter.
• Investors appear to be adopting a wary stance towards Dentsply Sirona until there is more clarity on the company's strategies to tackle the challenges affecting its future financial outlook.

07.10.2024 - XRAY Stock was down 19.9%

• The bearish movement in XRAY could be due to investors anticipating weaker-than-expected third-quarter earnings.
• Despite growth in specific segments like Wellspect Healthcare and Orthodontics, foreign exchange headwinds may have impacted overall performance.
• Investors might be taking a cautious approach, leading to a sell-off of XRAY shares before the earnings report.
• The uncertainty surrounding the company's financial performance in the face of external challenges could be driving the bearish sentiment in the market.

02.07.2024 - XRAY Stock was down 5.0%

• Second-quarter earnings of Dentsply Sirona (XRAY) were below analysts' expectations, with adjusted earnings per share and sales failing to meet estimates.
• Investor concerns about weak demand prompted the company to launch a restructuring plan, potentially impacting the stock's performance.
• Comparing the current figures to the previous year, the company experienced a decrease in both earnings and sales, influencing the negative market sentiment towards XRAY.
• Despite intentions to boost performance and shareholder value through restructuring and leadership adjustments, the initial reaction from investors may have triggered the downward movement in the stock price.